Cancer News and Research

Latest Cancer News and Research

Narrow band imaging colonoscopy identifies flat dysplastic lesions in ulcerative colitis patients

A pilot study from researchers at Kyushu University in Fukuoka, Japan, found that narrow band imaging (NBI) colonoscopy used in cancer surveillance for ulcerative colitis patients can identify flat dysplastic lesions.

19 Nov 2007

Morphotek issued new U.S patent for method to enhance the affinity of monoclonal antibodies

Morphotek, Inc., a subsidiary of Eisai Co., Ltd. has announced the issuance of United States Patent No. 7,235,643 B2 (the "643" patent).

19 Nov 2007

Cannabis compound may stop the spread of breast cancer cells

A compound found in cannabis may prove to be effective at helping stop the spread of breast cancer cells throughout the body.

19 Nov 2007

Managing the chronic care of patients is not being captured in today's reimbursement system

Full-time physicians spend an average of one full day a week providing services for patients that are not reimbursed by Medicare, according to a new study conducted by Jeffrey Farber, MD, Assistant Professor of Geriatrics at The Mount Sinai Medical Center, and published the journal Annals of Internal Medicine.

19 Nov 2007

U.S. approval of Nexavar (sorafenib) for inoperable liver cancer

The U.S. Food and Drug Administration has approved Nexavar (sorafenib) for use in patients with a form of liver cancer known as hepatocellular carcinoma, when the cancer is inoperable.

19 Nov 2007

Collaboration between medical specialties benefits patients

Opportunities for interdisciplinary cooperation between facial plastic surgeons and ophthalmologists have never been more important or promising, according to an editorial in the November/December issue of Archives of Facial Plastic Surgery, a theme issue on orbital and ophthalmic plastic surgery.

19 Nov 2007

Better detection accounts for increase in cases of thyroid cancer

Although still rare, the incidence of thyroid cancer is increasing. In this longitudinal study over 12 years from a large cancer registry, Kent and colleagues used the Ontario Cancer Registry to identify 7422 cases of differentiated thyroid cancer from 1990 to 2001.

19 Nov 2007

Anti-cancer drug made from soil bacteria

Scientists from the Helmholtz Centre for Infection Research (HZI) have discovered a class of natural substances that are produced by soil bacteria and prevent somatic cells from dividing.

19 Nov 2007

Subcutaneous administration of an antiemetic for treating vomiting caused by chemotherapy

The subcutaneous administration of granisetron, an antiemetic pharmaceutical drug (suitable for control of vomiting), achieves similar blood concentrations to those administered intravenously.

19 Nov 2007

Should the UK lower the age for prostate cancer detection in line with the USA?

19 Nov 2007

NewYork-Presbyterian/Weill Cornell opens new section of general surgery called Gastrointestinal Metabolic Surgery

Opening the doors to one of the first academic medical program dedicated to surgical treatment of type 2 diabetes, NewYork-Presbyterian Hospital/Weill Cornell Medical Center has created a new section of General Surgery called Gastrointestinal Metabolic Surgery.

19 Nov 2007

The immune system can stop the growth of a cancerous tumor without actually killing it

A multinational team of researchers has shown for the first time that the immune system can stop the growth of a cancerous tumor without actually killing it.

19 Nov 2007

High cost of pain in Australia

For the first time, a dollar value has been attached to the high cost of pain in Australia in an MBF Foundation funded study that reveals a massive annual cost of $34.3 billion -- nearly $11,000 for each of the estimated 3.2 million people grappling with pain.

19 Nov 2007

HIV-1 vaccines may not be as reliable against superinfection as once thought

Natural HIV-1 infection does not always elicit a protective immune response, according to a new study published November 16 in PLoS Pathogens.

19 Nov 2007

Avastin (bevacizumab) shows promise in phase II study of glioblastoma multiforme

Genentech, Inc. has announced that both study arms of a randomized, multi-center Phase II clinical study of Avastin (bevacizumab) administered alone or in combination with irinotecan chemotherapy demonstrated encouraging six-month progression-free survival (PFS) and objective response rate in patients with relapsed glioblastoma multiforme (GBM), the most common and aggressive type of brain cancer.

19 Nov 2007

Cancer News and Research

Latest Cancer News and Research

Narrow band imaging colonoscopy identifies flat dysplastic lesions in ulcerative colitis patients

Morphotek issued new U.S patent for method to enhance the affinity of monoclonal antibodies

Cannabis compound may stop the spread of breast cancer cells

Managing the chronic care of patients is not being captured in today's reimbursement system

U.S. approval of Nexavar (sorafenib) for inoperable liver cancer

Collaboration between medical specialties benefits patients

Better detection accounts for increase in cases of thyroid cancer

Anti-cancer drug made from soil bacteria

Subcutaneous administration of an antiemetic for treating vomiting caused by chemotherapy

Should the UK lower the age for prostate cancer detection in line with the USA?

NewYork-Presbyterian/Weill Cornell opens new section of general surgery called Gastrointestinal Metabolic Surgery

The immune system can stop the growth of a cancerous tumor without actually killing it

High cost of pain in Australia

HIV-1 vaccines may not be as reliable against superinfection as once thought

Avastin (bevacizumab) shows promise in phase II study of glioblastoma multiforme

Worrying about your health will just make you sick

Block buster cancer drug Avastin gives hope to brain tumor victims

Winter and vitamin D

Melatonin could actually be hurting you at night!

Pre-malignant mammary lesions in dogs and humans display many of the same characteristics

Industry Focus eBook - Oncology (1st Edition) eBook

Advancing brain microphysiological systems (bMPS)

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

Cancer News and Research

Latest Cancer News and Research

Industry Focus eBook - Oncology (1st Edition) eBook

Advancing brain microphysiological systems (bMPS)

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

Newsletters you may be interested in